A Graph Convolutional Neural Network Approach to Antibiotic Discovery
welcometothejungle.com
welcometothejungle.com
If this type of research interests anyone here, Genesis Therapeutics -- Stanford spinout and a16z-backed -- is hiring!
Here is our HN "who's hiring?" post. Join us in using deep learning to discover medicines for patients suffering from devastating diseases.
Genesis Therapeutics | South San Francisco, CA | Onsite | Full-time | https://www.genesistherapeutics.ai
We’re a hybrid AI + biotech company, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines.
- Core deep learning tech was invented by co-founder + CEO Evan Feinberg during his PhD at Stanford’s Pande lab (the lab that did Folding@Home). See the peer-reviewed PotentialNet paper: https://pubs.acs.org/doi/10.1021/acscentsci.8b00507
- Raised $4.1m seed round led by Andreessen Horowitz
- Our platform was validated in collaboration with a top-five pharma company, in a public paper: https://arxiv.org/abs/1903.11789
- In addition to strong software + AI talent, our small team has top drug discovery scientists who have collectively discovered eleven FDA-approved treatments
Here are our open roles:
- Software Engineer: https://jobs.genesistherapeutics.ai/apply/ILdjypU87G/Softwar....
- AI Engineer: https://jobs.genesistherapeutics.ai/apply/NAtx0CsIIL/AI-Engi....
Tech Stack: python, pytorch, postgres, docker, kubernetes, various computational chemistry libraries + tools
Please apply online, or email your resume to: ben@genesistherapeutics.ai
Side note: I worked with Kyle a few years ago on the MIT-MGH Deep Learning for Mammography project. I'm glad to see his work + brilliance being recognized.